Eurofarma Laboratorios SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eurofarma Laboratorios SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10932
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eurofarma Laboratorios SA (Eurofarma), formerly Bill Farmaceutica is a pharmaceutical company that manufactures and markets prescription, generic and veterinary drugs. The company offers prescription products such as aerosol ointment, alprazolam, acebrophylline, altiva, ebastel, fluoruracila, gemcitabine cloridate, and others. Its veterinary products comprise anesthetic L, aminofort, bertac liquid, genesis ivor pour-on, hipotac, and others. Eurofarma offers hospital drug products such as amoxicillin, amoxicillin + clavulanate, cephtriaxone sodium, cefepime hydrochloride, omeprazole sodium and others. The company operates in Argentina, Bolivia, Chile, Colombia, Guatemala, Peru and Uruguay. Eurofarma is headquartered in Sao Paulo, Brazil.

Eurofarma Laboratorios SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Dong-A ST Extends Licensing Agreement with Eurofarma 10
Melinta Therapeutics Expands Agreement with Eurofarma Lab 11
Cristalia, Biolab, Eurofarma And Libbs Enter Into Joint Venture For Biological Medicines 12
Licensing Agreements 13
Eurofarma Labs Enters into Licensing Agreement with Eisai 13
Summit Therapeutics Enters into Licensing Agreement with Eurofarma Laboratorios 14
Morphotek Enters into Licensing Agreement with Eurofarma Laboratorios 15
Eurofarma Laboratorios SA – Key Competitors 16
Eurofarma Laboratorios SA – Key Employees 17
Eurofarma Laboratorios SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Key Facts 2
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofarma Laboratorios SA, Deals By Therapy Area, 2012 to YTD 2018 8
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dong-A ST Extends Licensing Agreement with Eurofarma 10
Melinta Therapeutics Expands Agreement with Eurofarma Lab 11
Cristalia, Biolab, Eurofarma And Libbs Enter Into Joint Venture For Biological Medicines 12
Eurofarma Labs Enters into Licensing Agreement with Eisai 13
Summit Therapeutics Enters into Licensing Agreement with Eurofarma Laboratorios 14
Morphotek Enters into Licensing Agreement with Eurofarma Laboratorios 15
Eurofarma Laboratorios SA, Key Competitors 16
Eurofarma Laboratorios SA, Key Employees 17
Eurofarma Laboratorios SA, Subsidiaries 18
Eurofarma Laboratorios SA, Joint Venture 19

List of Figures
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eurofarma Laboratorios SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Eurofarma Laboratorios SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bio-Reference Laboratories Inc:企業の戦略的SWOT分析
    Bio-Reference Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • DLF Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DLF Limited Mergers and Acquisi …
  • Opcon AB (TRENT):企業財務及び戦略的SWOT分析
    Summary Opcon AB (Opcon) is an energy and environmental technology company that develops, produces and markets systems, and products for ecofriendly, efficient and low-resource energy usage. The company's services include handling systems for biomass, sludge and natural gas, industrial cooling and f …
  • AB Lesto (LES1L):企業概要、財務及び戦略的SWOT分析
    Summary AB LESTO (Lesto) is a power distribution company. The company supplies and distributes electric power. It operates medium and low voltage electricity distribution network. Lesto also provides network security services. Its other activities also include substituting a single-phase power syste …
  • Marion Energy Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Marion Energy Limited Mergers a …
  • Technofan SA:企業の戦略・SWOT・財務分析
    SummaryTechnofan SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Wellcome Trust:企業のM&A・事業提携・投資動向
    Wellcome Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wellcome Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Elantas Beck India Ltd (500123):企業概要、財務及び戦略的SWOT分析
    Summary Elantas Beck India Ltd (Elantas) is an insulating material manufacturing company. The company manufactures insulating materials for the electrical, construction and electronics industry. Its products include primary insulation, secondary insulation, and electronic and engineering materials. …
  • DCC plc:企業のM&A・提携・投資分析
    DCC plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DCC plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Urstadt Biddle Properties Inc.:企業の戦略・SWOT・財務分析
    SummaryUrstadt Biddle Properties Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Kuwait Investment Authority:電力:M&Aディール及び事業提携情報
    Summary The Kuwait Investment Authority (KIA) is an asset management company. It offers fund management and investment management services. The company is responsible for the management and administration of the General Reserve Fund (GRF), apart from the assets of the Future Generations Fund (FGF). …
  • Korea Petrochemical Ind. Co., Ltd. (006650):企業の財務及び戦略的SWOT分析
    Summary Korea Petrochemical Ind. Co., Ltd. (KPICL) is a chemical company that manufactures and markets petrochemical products and synthetic resins. The company’s products include ethylene, BTX, propylene, polypropylene and high density polyethylene, naphtha cracking center (NCC) products, polypropyl …
  • Indo-National Limited (NIPPOBATRY):企業の財務及び戦略的SWOT分析
    Summary Indo-National Limited (Indo-National) formerly Nippo Batteries Co. Ltd., is an energy equipment company that manufactures batteries. The company designs, produces and commercializes batteries and related products. It offers product under three categories, including rechargeable, non-recharge …
  • Ventas, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ventas, Inc. Mergers and Acquis …
  • Daktronics Inc (DAKT):企業の財務・戦略的SWOT分析
    Daktronics Inc (DAKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The Sage Group plc:企業の戦略・SWOT・財務分析
    SummaryThe Sage Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • BOC Hong Kong (Holdings) Ltd:戦略・SWOT・企業財務分析
    BOC Hong Kong (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary BOC Hong Kong (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Tampa Electric Co:企業の戦略的SWOT分析
    Tampa Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Zogenix Inc (ZGNX):企業財務及び戦略的SWOT分析
    Summary Zogenix Inc (Zogenix) is a pharmaceutical company that develops and commercializes injectable therapies and delivery systems for treating central nervous system disorders and pain. The company’s product portfolio includes Zohydro ER, Sumavel DosePro and undisclosed dosepro CNS product candid …
  • SurModics Inc (SRDX)-医療機器分野:企業M&A・提携分析
    Summary SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆